BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37839398)

  • 1. "Don't Add Fuel to the Fire"- Hyperhemolysis Syndrome in a Pregnant Woman with Compound Sickle Cell Disease/β0-Thalassemia: Case Report and Review of the Literature.
    Rihsling A; Simeunovic H; Sanchez S; Henny C; Lejon Crottet S; Mansouri Teleghani B; Daskalakis M; Müller M; Raio L; Rovó A
    Acta Haematol; 2024; 147(3):378-387. PubMed ID: 37839398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β-thalassemia during perinatal transfusion.
    Wu Y; Ji Y; Dai B; Guo F; Wu Y; He Z; Mo C; Wu S; Hu Y
    Transfus Med; 2021 Feb; 31(1):24-29. PubMed ID: 33331032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baby on board: what you need to know about pregnancy in the hemoglobinopathies.
    Naik RP; Lanzkron S
    Hematology Am Soc Hematol Educ Program; 2012; 2012():208-14. PubMed ID: 23233583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.
    Lee LE; Beeler BW; Graham BC; Cap AP; Win N; Chen F
    Transfusion; 2020 Jan; 60(1):30-35. PubMed ID: 31642065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of hemoglobin electrophoresis to distinguish between severe delayed hemolytic transfusion reaction versus hyperhemolysis syndrome.
    Lukin R; Law JY; Lokhandwala PM
    Transfus Apher Sci; 2024 Jun; 63(3):103919. PubMed ID: 38582651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far.
    Meenan J; Hall R; Badle S; Chatterjee B; Win N; Tsitsikas DA
    Transfusion; 2022 Mar; 62(3):546-550. PubMed ID: 35092617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study.
    Koshy M; Burd L; Wallace D; Moawad A; Baron J
    N Engl J Med; 1988 Dec; 319(22):1447-52. PubMed ID: 3054555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell thalassemia in pregnancy: a case report.
    Carpani G; Bozzetti P; Cetin I; Tel A; Moroni GA
    J Matern Fetal Med; 1996; 5(1):28-30. PubMed ID: 8796762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red cell exchange is not effective for patients with sickle cell anaemia and coexisting warm autoantibody haemolysis.
    Baron JM; Baron BW
    Blood Transfus; 2010 Oct; 8(4):303-6. PubMed ID: 20967174
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review.
    Vasanthamohan L; Choo S; Marshall T; Symons YT; Matsui D; Eastabrook G; Solh Z
    Transfusion; 2020 Oct; 60(10):2448-2455. PubMed ID: 32851670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhemolysis syndrome complicating pregnancy in homozygous δβ-thalassemia.
    Mechery J; Abidogun K; Crosfill F; Jip J
    Hemoglobin; 2012; 36(2):183-5. PubMed ID: 22239462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhaemolytic Syndrome in Sickle Cell Disease: Clearing the Cobwebs.
    Madu AJ; Ugwu AO; Efobi C
    Med Princ Pract; 2021; 30(3):236-243. PubMed ID: 33176303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of hyperhemolysis syndrome in sickle cell disease and concomitant COVID-19.
    Green A; Jones H; Nero A; Ibrahim IF; Sarode R; Scheid LM; Webb CB; Adkins BD; Yates SG
    Transfus Apher Sci; 2023 Aug; 62(4):103712. PubMed ID: 37149492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.
    Fuja C; Kothary V; Carll TC; Singh S; Mansfield P; Wool GD
    Transfusion; 2022 Jul; 62(7):1446-1451. PubMed ID: 35588309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloimmunization and hyperhemolysis in sickle cell disease.
    Pirenne F; Pondarré C
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):653-659. PubMed ID: 38066873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of cesarean delivery in a parturient with sickle cell disease.
    Romano D; Craig H; Katz D
    Int J Obstet Anesth; 2020 Feb; 41():104-107. PubMed ID: 31610938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition.
    Mwesigwa S; Moulds JM; Chen A; Flanagan J; Sheehan VA; George A; Hanchard NA
    Transfusion; 2018 Mar; 58(3):726-735. PubMed ID: 29210071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A delayed hemolytic transfusion reaction after partial exchange transfusion for sickle cell disease in pregnancy: a case report and review of the literature.
    Brumfield CG; Huddleston JF; DuBois LB; Harris BA
    Obstet Gynecol; 1984 Mar; 63(3 Suppl):13S-15S. PubMed ID: 6700873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ; Shenoy S; Goodnough LT
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.